# Tilray Brands, Inc. (TLRY) · Edgar & Edgarette company card

> Tilray Brands (TLRY) grew revenue 11.5% in FY2026 to $915 million, operating margin -6.9% against a 0.7% median for medicinal chemicals & botanical products, equity 69.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1731348 · fiscal year ended 2026-05-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/TLRY) · [JSON](https://www.pops4.com/boards/company/TLRY.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $915M |
| Revenue growth, 1 year | 11.5% |
| Revenue growth per year | 9.9% |
| Operating margin | -6.9% (prior year -277.9%) |
| Net margin | -13.3% |
| Operating cash flow | −$69M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $226M |
| Long-term debt | — |
| Total assets | $2.3B |
| Total equity | $1.6B |
| Equity ÷ assets | 69.3% |
| Return on equity | -7.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -3.61 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; operating loss: a margin of -6.9% in FY2026
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $915.5M (FY2026). Experience: revenue up 11.5% on the year, up 9.9% a year over 4 years; operating margin -6.9%, up from -277.9%. Soundness: equity 69.3% of assets, return on equity -7.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $855.3M and $1.2B next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $786.5M to $1.3B. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, medicinal chemicals & botanical products): operating margin -6.9% against a 0.7% median; growth 11.5% against 1.7%.

Range logged 2026-09-29, receipt 819d94dd227d704d, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 10-Q · filed 2026-10-08 · [filing](https://www.sec.gov/Archives/edgar/data/1731348/000143774926032382/0001437749-26-032382-index.htm)
- 8-K · filed 2026-10-08 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1731348/000117184326006527/0001171843-26-006527-index.htm)
- DEF 14A · filed 2026-09-28 · [filing](https://www.sec.gov/Archives/edgar/data/1731348/000114036126037827/0001140361-26-037827-index.htm)
- 8-K · filed 2026-09-14 · 3.02 Unregistered Sales of Equity Securities · [filing](https://www.sec.gov/Archives/edgar/data/1731348/000114036126036507/0001140361-26-036507-index.htm)
- 8-K · filed 2026-08-10 · 3.02 Unregistered Sales of Equity Securities · [filing](https://www.sec.gov/Archives/edgar/data/1731348/000114036126032052/0001140361-26-032052-index.htm)
- 10-K · filed 2026-07-28 · [filing](https://www.sec.gov/Archives/edgar/data/1731348/000143774926024698/0001437749-26-024698-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001731348.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1731348

## Cite

POPS4, Edgar & Edgarette: Tilray Brands, Inc. (TLRY) company card, from the company's own SEC filings, accessed 2026-11-14, https://www.pops4.com/boards/company/TLRY. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.